DE60326001D1 - Sterile immunogene nicht-tumorigene tumorzell-zusammensetzungen und verfahren - Google Patents

Sterile immunogene nicht-tumorigene tumorzell-zusammensetzungen und verfahren

Info

Publication number
DE60326001D1
DE60326001D1 DE60326001T DE60326001T DE60326001D1 DE 60326001 D1 DE60326001 D1 DE 60326001D1 DE 60326001 T DE60326001 T DE 60326001T DE 60326001 T DE60326001 T DE 60326001T DE 60326001 D1 DE60326001 D1 DE 60326001D1
Authority
DE
Germany
Prior art keywords
cells
sterile
immunogenous
tumor cell
cell compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60326001T
Other languages
English (en)
Inventor
Martin V Haspel
Nicholas Pomato
Michael G Hanna
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intracel Resources LLC
Original Assignee
Intracel Resources LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Intracel Resources LLC filed Critical Intracel Resources LLC
Application granted granted Critical
Publication of DE60326001D1 publication Critical patent/DE60326001D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/04—Antineoplastic agents specific for metastasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
DE60326001T 2002-02-22 2003-02-21 Sterile immunogene nicht-tumorigene tumorzell-zusammensetzungen und verfahren Expired - Lifetime DE60326001D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US35843102P 2002-02-22 2002-02-22
PCT/US2003/005154 WO2003072032A2 (en) 2002-02-22 2003-02-21 Sterile immunogenic non-tumorigenic tumor cell compositions and methods

Publications (1)

Publication Number Publication Date
DE60326001D1 true DE60326001D1 (de) 2009-03-12

Family

ID=27765958

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60326001T Expired - Lifetime DE60326001D1 (de) 2002-02-22 2003-02-21 Sterile immunogene nicht-tumorigene tumorzell-zusammensetzungen und verfahren

Country Status (9)

Country Link
US (1) US7628996B2 (de)
EP (1) EP1567175B1 (de)
JP (1) JP2006507214A (de)
CN (1) CN1774255A (de)
AT (1) ATE421328T1 (de)
AU (1) AU2003230553B2 (de)
CA (1) CA2476999C (de)
DE (1) DE60326001D1 (de)
WO (1) WO2003072032A2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7674456B2 (en) * 2004-06-14 2010-03-09 Charles Wiseman Breast cancer cell lines and uses thereof
US20080286249A1 (en) * 2006-01-12 2008-11-20 Varney Timothy R Use of mesenchymal stem cells for treating genetic diseases and disorders
US20070253931A1 (en) * 2006-01-12 2007-11-01 Osiris Therapeutics, Inc. Use of mesenchymal stem cells for treating genetic diseases and disorders
CN101855549A (zh) 2007-09-12 2010-10-06 耶达研究及发展有限公司 在免疫豁免部位内治疗肿瘤的方法
CN102186499B (zh) * 2008-08-20 2015-05-20 Ibc医药公司 用于癌症治疗的对接和锁定(dnl)疫苗
EP2538988B1 (de) 2010-02-26 2019-01-30 DeCell Technologies Inc. Verfahren zur gewebe-entzellularisierung
US8377143B2 (en) 2010-07-06 2013-02-19 Cryolife, Inc. Tissue implants for implantation and methods for preparing the same
US20120009644A1 (en) * 2010-07-06 2012-01-12 Cryolife, Inc. Tissue Implants for Implantation and Methods for Preparing the Same
WO2012069067A1 (de) 2010-11-26 2012-05-31 Vakzine Projekt Management Gmbh Verfahren zur herstellung eines immunotherapeutikums
EP3049155A1 (de) * 2013-09-27 2016-08-03 Vaccinogen International Partners, LP Autologe krebsimpfstoffe und verfahren
AU2014341866B2 (en) 2013-11-04 2018-07-05 Lifecell Corporation Methods of removing alpha-galactose
US10099855B1 (en) 2015-08-14 2018-10-16 II Michael S. Higgins Can liner cinch device and method of use
CN111386042B (zh) * 2017-12-04 2023-01-31 热生物制品有限公司 基于细胞的疫苗的生产
CN110124021A (zh) * 2019-05-15 2019-08-16 迪亚思生命科技(武汉)有限公司 一种新型肿瘤疫苗的制备方法
CN112316147A (zh) * 2019-08-01 2021-02-05 成都夸常奥普医疗科技有限公司 包含组织细胞的半流体和活性成分的药物组合物以及该组合物的制备方法
CN112316148A (zh) * 2019-08-01 2021-02-05 成都夸常奥普医疗科技有限公司 包含血浆的半流体的应用、包含该半流体和活性成分的药物组合物及其制备方法
WO2022068925A1 (zh) * 2020-09-30 2022-04-07 成都夸常奥普医疗科技有限公司 动物非致病性细胞相关组分的应用和包含该组分的药物组合物

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ210867A (en) 1984-01-31 1989-01-06 Litton Bionetics Inc Tumour-specific monoclonal antibodies, production thereof and use
US4828991A (en) 1984-01-31 1989-05-09 Akzo N.V. Tumor specific monoclonal antibodies
US4878891A (en) 1987-06-25 1989-11-07 Baylor Research Foundation Method for eradicating infectious biological contaminants in body tissues
JP3297433B2 (ja) 1989-06-15 2002-07-02 ローヌ−プーラン ローラー インターナショナル （ホウルディングス） インコーポレイテッド ウイルスで汚染された薬理組成物中のウイルスの不活性化方法
US5658722A (en) 1990-05-15 1997-08-19 New York Blood Center, Inc. Process for the sterilization of biological compositions using UVA1 irradiation
AU677165B2 (en) * 1991-10-04 1997-04-17 Johns Hopkins University School Of Medicine, The The regulation of systemic immune responses utilizing cytokines and antigens
US6090385A (en) 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
US6218166B1 (en) * 1994-12-09 2001-04-17 John Wayne Cancer Institute Adjuvant incorporation into antigen carrying cells: compositions and methods
CA2214503C (en) 1995-03-17 2002-05-07 The Regents Of The University Of California Method for treating tumors
US5532141A (en) 1995-06-13 1996-07-02 Holler; Larry D. Process for obtaining ganglioside lipids
US5788941A (en) 1996-01-31 1998-08-04 Steris Corporation Method of sterilization of bone tussue
US5730933A (en) 1996-04-16 1998-03-24 Depuy Orthopaedics, Inc. Radiation sterilization of biologically active compounds
US6506339B1 (en) 1997-02-10 2003-01-14 Biomedical Design, Inc. Method of sterilization
EP1119365A4 (de) 1997-07-24 2003-08-13 Univ Jefferson Zusammensetzung und methode zur verwendung von tumorzellen
US6270723B1 (en) 1998-06-15 2001-08-07 Bbi Bioseq, Inc. Rapid cryobaric sterilization and vaccine preparation
US6299873B1 (en) 1998-06-17 2001-10-09 University Of Connecticut Method for improvement of radiation therapy of malignant tumors
GB9827103D0 (en) * 1998-12-10 1999-02-03 Onyvax Ltd New cancer treatments
US6406699B1 (en) 1999-10-05 2002-06-18 Gary W. Wood Composition and method of cancer antigen immunotherapy
US6180357B1 (en) 1999-10-08 2001-01-30 Arius Research, Inc. Individualized patient-specific anti-cancer antibodies

Also Published As

Publication number Publication date
AU2003230553A2 (en) 2003-09-09
CA2476999C (en) 2015-09-15
CA2476999A1 (en) 2003-09-04
AU2003230553A1 (en) 2003-09-09
US20030228300A1 (en) 2003-12-11
WO2003072032A2 (en) 2003-09-04
EP1567175B1 (de) 2009-01-21
JP2006507214A (ja) 2006-03-02
WO2003072032A3 (en) 2005-06-02
EP1567175A4 (de) 2006-03-29
AU2003230553B2 (en) 2008-08-21
EP1567175A2 (de) 2005-08-31
ATE421328T1 (de) 2009-02-15
US7628996B2 (en) 2009-12-08
CN1774255A (zh) 2006-05-17

Similar Documents

Publication Publication Date Title
DE60326001D1 (de) Sterile immunogene nicht-tumorigene tumorzell-zusammensetzungen und verfahren
NO20045354L (no) Fremgangsmater for behandling av angiogenese, turmorvekst og metastaser
WO2008039874A3 (en) Cancer stem cell antigen vaccines and methods
NO20011586D0 (no) Nye metoder for terapeutisk vaksinasjon
WO2004098535A3 (en) Modified antibodies to prostate-specific membrane antigen and uses thereof
DK1718737T3 (da) Cancerøs sygdomsmodificerende antistoffer
RU2012127685A (ru) Устройства и способы для активной клеточной иммунотерапии рака путем применения опухолевых клеток, уничтоженных при помощи высокого гидростатического давления, и дендритных клеток
HUP0402656A2 (hu) Sejtterápiás eljárás tumorok kezelésére
CY1112575T1 (el) Βελτιωμενα αδρανοποιημενα εμβολια fcv
ATE512668T1 (de) Allogenes tumortherapeutikum
WO2008051852A3 (en) Extracellular matrix cancer vaccine adjuvant
ATE410155T1 (de) Verwendung von cyclin-d1-hemmern zur brustkrebsbehandlung
WO2003033520A3 (en) Anticancer vaccine and diganostic methods and reagents
MX2021010862A (es) Arn terapeutico para el cancer de prostata.
DE60334382D1 (de) Verfahren zur herstellung von temperaturinduzierten tumorzell-lysaten zur verwendung als immunogene verbindungen
MX2021014226A (es) Arn terapeutico para cancer de ovario.
CY1111522T1 (el) 84p2a9: ειδικη σε προστατη και ορχεις πρωτεϊνη που εκφραζεται σε υψηλο βαθμο στον προστατικο καρκινο
ES2141089T3 (es) Gp75 como vacuna tumoral para melanoma.
MX2007008441A (es) Metodo para producir una vacuna para el tratamiento de cancer.
WO2023049636A3 (en) Cancer therapy compositions and uses thereof
NO20020615D0 (no) Vaksine
MXPA01010186A (es) Composiciones y metodos para el tratamiento y diagnostico de cancer de mama.
WO2012026820A3 (en) Immunotherapeutic method for treating prostate cancer
WO2006105279A3 (en) Defective sindbis viral vectors
MY160857A (en) A cancer vaccine

Legal Events

Date Code Title Description
8364 No opposition during term of opposition